查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1807676

细胞疗法製造的全球市场:市场规模·占有率·趋势，按产业分析 (供给来源·各细胞类型·各适应症·各手术规模·各终端用户·各地区)，2025～2034年的市场预测

Cell Therapy Manufacturing Market Size, Share, Trends, & Industry Analysis Report By Source, By Cell Type, By Indication, By Scale of Operation, By End User, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，细胞疗法製造市场规模将达到 241.8 亿美元。该报告深入分析了当前的市场动态，并分析了未来的市场成长。

细胞疗法製造是指用于再生医学、肿瘤学和免疫相关疾病的自体和同种异体细胞疗法的大规模生产和加工。这些製造过程遵循严格的监管标准，以确保细胞活力、遗传稳定性和治疗效果。

全球癌症和慢性退化性疾病的发生率不断上升，推动了市场成长，这推动了对先进细胞免疫疗法的需求。再生医学研发支出的不断增加，加上政府资金投入和有利的监管框架，正在进一步加速产品开发。

细胞疗法製造市场：分析概述

按来源划分，自体细胞疗法将在2024年占最大的市场占有率。这是由于针对特定患者的疗法越来越多地被采用，这些疗法可以降低免疫排斥风险并改善肿瘤和罕见遗传疾病的治疗效果。

依细胞类型划分，T细胞将占市场主导地位。这是由于复杂治疗性蛋白质的生产效率高，可确保生物製剂製造中更高的疗效和安全性。

按适应症划分，预计神经系统疾病领域将增长最快，这得益于帕金森氏症、多发性硬化症和脊髓损伤等疾病的干细胞再生疗法临床研究的增加。

以程序规模计算，由于各治疗领域的临床试验数量不断增加，临床治疗领域将在2024年占主导地位。

以最终用户计算，预计学术和研究机构将在资金和细胞疗法合作的推动下实现最快成长。

受政府和私人对再生医学研究资金不断增加的推动，北美在2024年主导了全球细胞疗法製造市场。

受生物技术扩张和再生医学投资的推动，亚太地区呈现稳定成长。

全球主要市场参与者包括龙沙集团 (Lonza Group AG)、Minaris Regenerative Medicine、默克集团 (Merck KGaA)、赛默飞世尔科技 (Thermo Fisher Scientific Inc.)、康泰伦特公司 (Catalent, Inc.)、Charles River Laboratories、Cell Therapies Pular Fest、Fyrapyfiler Ltd. AG)、AGC Biologics、Cellistic 和 Bio-Techne。

目录

第1章 简介

第2章 摘要整理

第3章 分析方法

第4章 全球细胞疗法製造市场洞察

  • 市场概述
  • 细胞疗法製造的市场动态
    • 促进因素和机会
      • 全球研发支出不断增加
      • 全球癌症患者人数不断增加
    • 限制与课题
      • 製造成本高
  • PESTLE 分析
  • 细胞疗法製造市场趋势
  • 价值链分析

第5章 全球细胞疗法製造市场:供给来源

  • 主要的分析结果
  • 简介
  • 自体细胞疗法
  • 同类细胞疗法

第6章 全球细胞疗法製造市场:各细胞类型

  • 主要的分析结果
  • 简介
  • T细胞
  • 干细胞
  • 自然杀手(NK)细胞
  • 树突状细胞
  • 其他

第7章 全球细胞疗法製造市场:各适应症

  • 主要的分析结果
  • 简介
  • 肿瘤
  • 心血管疾病
  • 神经疾病
  • 整形外科·肌肉骨骼系统疾病
  • 自体免疫疾病
  • 其他

第8章 全球细胞疗法製造市场:各手术规模

  • 主要的分析结果
  • 简介
  • 临床
  • 上市
  • 前临床

第9章 全球细胞疗法製造市场:各终端用户

  • 主要的分析结果
  • 简介
  • 医院·专门诊所
  • 製药·生物科技企业
  • 学术·研究机关

第10章 全球细胞疗法製造市场:各地区

  • 主要的分析结果
  • 简介
    • 细胞疗法製造市场分析:各地区 (2020～2034年)
  • 北美
    • 北美:各供给来源(2020～2034年)
    • 北美:各细胞类型(2020～2034年)
    • 北美:各适应症(2020～2034年)
    • 北美:各手术规模(2020～2034年)
    • 北美:各终端用户(2020～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各供给来源(2020～2034年)
    • 欧洲:各细胞类型(2020～2034年)
    • 欧洲:各适应症(2020～2034年)
    • 欧洲:各手术规模(2020～2034年)
    • 欧洲:各终端用户(2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各供给来源(2020～2034年)
    • 亚太地区:各细胞类型(2020～2034年)
    • 亚太地区:各适应症(2020～2034年)
    • 亚太地区:各手术规模(2020～2034年)
    • 亚太地区:各终端用户(2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各供给来源(2020～2034年)
    • 中东·非洲:各细胞类型(2020～2034年)
    • 中东·非洲:各适应症(2020～2034年)
    • 中东·非洲:各手术规模(2020～2034年)
    • 中东·非洲:各终端用户(2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各供给来源(2020～2034年)
    • 南美:各细胞类型(2020～2034年)
    • 南美:各适应症(2020～2034年)
    • 南美:各手术规模(2020～2034年)
    • 南美:各终端用户(2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第11章 竞争情形

  • 事业扩大·企业收购的分析
    • 事业扩大
    • 企业收购
  • 联盟/合作/协定/公开

第12章 企业简介

  • AGC Biologics
  • Bayer AG
  • Bio-Techne
  • Catalent, Inc.
  • Cell Therapies Pty Ltd.
  • Cellistic
  • Charles River Laboratories
  • Fujifilm Cellular Dynamics Inc.
  • Lonza Group AG
  • Merck KGaA
  • Minaris Regenerative Medicine
  • Thermo Fisher Scientific Inc.
Product Code: PM6118

The cell therapy manufacturing market size is expected to reach USD 24.18 billion by 2034, according to a new study by Polaris Market Research. The report "Cell Therapy Manufacturing Market Share, Size, Trends, Industry Analysis Report: By Source, By Cell Type, By Indication, By Scale of Operation, By End User, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Cell therapy manufacturing refers to the large-scale production and processing of autologous and allogeneic cell-based therapies used for regenerative medicine, oncology, and immune-related disorders. These manufacturing processes are conducted under stringent regulatory standards to ensure cell viability, genetic stability, and therapeutic efficacy.

The market growth is fueled by the increasing global incidence of cancer and chronic degenerative diseases, which is driving demand for advanced cell-based immunotherapies. Rising R&D expenditure in regenerative medicine coupled with government funding and favorable regulatory frameworks is further accelerating product development.

Cell Therapy Manufacturing Market Report Highlights

Based on source, the autologous cell therapy segment accounted for the largest market share in 2024, due to the growing adoption of patient-specific therapies offering reduced risk of immune rejection and improved treatment outcomes in oncology and rare genetic disorders.

Based on cell type, the T-cell segment dominated the market, driven by its high efficiency in producing complex therapeutic proteins that ensures better efficacy and safety in biologics manufacturing

Based on indication, the neurological disorders segment is expected to witness the fastest growth, fueled by increasing clinical research in stem cell-based regenerative therapies for conditions such as Parkinson's disease, multiple sclerosis, and spinal cord injuries.

Based on scale of operation, the clinical segment held the dominant share in 2024, due to the rising number of clinical trials across various therapeutic areas.

Based on end user, the academic & research institutes is expected to witness the fastest growth, driven by funding and cell therapy collaborations.

North America dominated the global cell therapy manufacturing market in 2024, fueled by expanding government and private funding for regenerative medicine research.

Asia Pacific witnessed a steady growth, driven by biotech expansion and regenerative medicine investments.

A few global key market players include Lonza Group AG, Minaris Regenerative Medicine, Merck KGaA, Thermo Fisher Scientific Inc., Catalent, Inc., Charles River Laboratories, Cell Therapies Pty Ltd., Fujifilm Cellular Dynamics Inc., Bayer AG, AGC Biologics, Cellistic, and Bio-Techne.

Polaris Market Research has segmented the market report on the basis of source, cell type, indication, scale of operation, end user, and region:

By Source Outlook (Revenue, USD Billion, 2020-2034)

Autologous Cell Therapy

Allogeneic Cell Therapy

By Cell Type Outlook (Revenue, USD Billion, 2020-2034)

T-Cells

Stem Cells

Natural Killer (NK) Cells

Dendritic Cells

Others

By Indication (Revenue, USD Billion, 2020-2034)

Oncology

Cardiovascular Diseases

Neurological Disorders

Orthopedic & Musculoskeletal Disorders

Autoimmune Diseases

Others

By Scale of Operation (Revenue, USD Billion, 2020-2034)

Clinical

Commercial

Pre-clinical

By End User (Revenue, USD Billion, 2020-2034)

Hospitals & Specialty Clinics

Pharmaceutical & Biotechnology Companies

Academic & Research Institutes

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cell Therapy Manufacturing Market Insights

  • 4.1. Cell Therapy Manufacturing Market - Market Snapshot
  • 4.2. Cell Therapy Manufacturing Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Global R&D Expenditure
      • 4.2.1.2. Increasing Global Cancer Cases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Manufacturing Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cell Therapy Manufacturing Market Trends
  • 4.6. Value Chain Analysis

5. Global Cell Therapy Manufacturing Market, by Source

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • 5.3. Autologous Cell Therapy
    • 5.3.1. Global Cell Therapy Manufacturing Market, by Autologous Cell Therapy, by Region, 2020-2034 (USD Billion)
  • 5.4. Allogeneic Cell Therapy
      • 5.4.1.1. Global Cell Therapy Manufacturing Market, by Allogeneic Cell Therapy, by Region, 2020-2034 (USD Billion)

6. Global Cell Therapy Manufacturing Market, by Cell Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • 6.3. T-Cells
    • 6.3.1. Global Cell Therapy Manufacturing Market, by T-Cells, by Region, 2020-2034 (USD Billion)
  • 6.4. Stem Cells
    • 6.4.1. Global Cell Therapy Manufacturing Market, by Stem Cells, by Region, 2020-2034 (USD Billion)
  • 6.5. Natural Killer (NK) Cells
    • 6.5.1. Global Cell Therapy Manufacturing Market, by Natural Killer (NK) Cells, by Region, 2020-2034 (USD Billion)
  • 6.6. Dendritic Cells
    • 6.6.1. Global Cell Therapy Manufacturing Market, by Dendritic Cells, by Region, 2020-2034 (USD Billion)
  • 6.7. Others
    • 6.7.1. Global Cell Therapy Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Cell Therapy Manufacturing Market, by Indication

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • 7.3. Oncology
    • 7.3.1. Global Cell Therapy Manufacturing Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 7.4. Cardiovascular Diseases
    • 7.4.1. Global Cell Therapy Manufacturing Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Billion)
  • 7.5. Neurological Disorders
    • 7.5.1. Global Cell Therapy Manufacturing Market, by Neurological Disorders, by Region, 2020-2034 (USD Billion)
  • 7.6. Orthopedic & Musculoskeletal Disorders
    • 7.6.1. Global Cell Therapy Manufacturing Market, by Orthopedic & Musculoskeletal Disorders, by Region, 2020-2034 (USD Billion)
  • 7.7. Autoimmune Diseases
    • 7.7.1. Global Cell Therapy Manufacturing Market, by Autoimmune Diseases, by Region, 2020-2034 (USD Billion)
  • 7.8. Others
    • 7.8.1. Global Cell Therapy Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Cell Therapy Manufacturing Market, by Scale of Operation

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • 8.3. Clinical
    • 8.3.1. Global Cell Therapy Manufacturing Market, by Clinical, by Region, 2020-2034 (USD Billion)
  • 8.4. Commercial
    • 8.4.1. Global Cell Therapy Manufacturing Market, by Commercial, by Region, 2020-2034 (USD Billion)
  • 8.5. Pre-clinical
    • 8.5.1. Global Cell Therapy Manufacturing Market, by Pre-clinical, by Region, 2020-2034 (USD Billion)

9. Global Cell Therapy Manufacturing Market, by End User

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 9.3. Hospitals & Specialty Clinics
    • 9.3.1. Global Cell Therapy Manufacturing Market, by Hospitals & Specialty Clinics, by Region, 2020-2034 (USD Billion)
  • 9.4. Pharmaceutical & Biotechnology Companies
    • 9.4.1. Global Cell Therapy Manufacturing Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Billion)
  • 9.5. Academic & Research Institutes
    • 9.5.1. Global Cell Therapy Manufacturing Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Billion)

10. Global Cell Therapy Manufacturing Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Cell Therapy Manufacturing Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 10.3. Cell Therapy Manufacturing Market - North America
    • 10.3.1. North America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.3.2. North America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.3.3. North America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.3.4. North America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.3.5. North America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.3.6. Cell Therapy Manufacturing Market - U.S.
      • 10.3.6.1. U.S.: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.3.6.2. U.S.: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.3.6.3. U.S.: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.3.6.4. U.S.: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.3.6.5. U.S.: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.3.7. Cell Therapy Manufacturing Market - Canada
      • 10.3.7.1. Canada: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.3.7.2. Canada: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.3.7.3. Canada: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.3.7.4. Canada: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.3.7.5. Canada: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.4. Cell Therapy Manufacturing Market - Europe
    • 10.4.1. Europe: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.4.2. Europe: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.4.3. Europe: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.4.4. Europe: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.4.5. Europe: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.4.6. Cell Therapy Manufacturing Market - UK
      • 10.4.6.1. UK: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.4.6.2. UK: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.4.6.3. UK: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.4.6.4. UK: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.4.6.5. UK: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.4.7. Cell Therapy Manufacturing Market - France
      • 10.4.7.1. France: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.4.7.2. France: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.4.7.3. France: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.4.7.4. France: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.4.7.5. France: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.4.8. Cell Therapy Manufacturing Market - Germany
      • 10.4.8.1. Germany: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.4.8.2. Germany: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.4.8.3. Germany: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.4.8.4. Germany: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.4.8.5. Germany: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.4.9. Cell Therapy Manufacturing Market - Italy
      • 10.4.9.1. Italy: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.4.9.2. Italy: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.4.9.3. Italy: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.4.9.4. Italy: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.4.9.5. Italy: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.4.10. Cell Therapy Manufacturing Market - Spain
      • 10.4.10.1. Spain: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.4.10.2. Spain: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.4.10.3. Spain: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.4.10.4. Spain: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.4.10.5. Spain: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.4.11. Cell Therapy Manufacturing Market - Netherlands
      • 10.4.11.1. Netherlands: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.4.11.2. Netherlands: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.4.11.3. Netherlands: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.4.11.4. Netherlands: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.4.11.5. Netherlands: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.4.12. Cell Therapy Manufacturing Market - Russia
      • 10.4.12.1. Russia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.4.12.2. Russia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.4.12.3. Russia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.4.12.4. Russia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.4.12.5. Russia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.4.13. Cell Therapy Manufacturing Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.4.13.2. Rest of Europe: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.4.13.3. Rest of Europe: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.4.13.4. Rest of Europe: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.4.13.5. Rest of Europe: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.5. Cell Therapy Manufacturing Market - Asia Pacific
    • 10.5.1. Asia Pacific: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.5.2. Asia Pacific: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.5.3. Asia Pacific: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.5.4. Asia Pacific: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.5.5. Asia Pacific: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.5.6. Cell Therapy Manufacturing Market - China
      • 10.5.6.1. China: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.5.6.2. China: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.5.6.3. China: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.5.6.4. China: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.5.6.5. China: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.5.7. Cell Therapy Manufacturing Market - India
      • 10.5.7.1. India: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.5.7.2. India: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.5.7.3. India: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.5.7.4. India: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.5.7.5. India: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.5.8. Cell Therapy Manufacturing Market - Malaysia
      • 10.5.8.1. Malaysia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.5.8.2. Malaysia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.5.8.3. Malaysia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.5.8.4. Malaysia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.5.8.5. Malaysia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.5.9. Cell Therapy Manufacturing Market - Japan
      • 10.5.9.1. Japan: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.5.9.2. Japan: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.5.9.3. Japan: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.5.9.4. Japan: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.5.9.5. Japan: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.5.10. Cell Therapy Manufacturing Market - Indonesia
      • 10.5.10.1. Indonesia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.5.10.2. Indonesia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.5.10.3. Indonesia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.5.10.4. Indonesia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.5.10.5. Indonesia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.5.11. Cell Therapy Manufacturing Market - South Korea
      • 10.5.11.1. South Korea: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.5.11.2. South Korea: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.5.11.3. South Korea: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.5.11.4. South Korea: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.5.11.5. South Korea: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.5.12. Cell Therapy Manufacturing Market - Australia
      • 10.5.12.1. Australia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.5.12.2. Australia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.5.12.3. Australia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.5.12.4. Australia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.5.12.5. Australia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.5.13. Cell Therapy Manufacturing Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.5.13.2. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.5.13.3. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.5.13.4. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.5.13.5. Rest of Asia Pacific: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.6. Cell Therapy Manufacturing Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.6.2. Middle East & Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.6.3. Middle East & Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.6.4. Middle East & Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.6.5. Middle East & Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.6.6. Cell Therapy Manufacturing Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.6.6.2. Saudi Arabia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.6.7. Cell Therapy Manufacturing Market - UAE
      • 10.6.7.1. UAE: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.6.7.2. UAE: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.6.7.3. UAE: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.6.7.4. UAE: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.6.7.5. UAE: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.6.8. Cell Therapy Manufacturing Market - Israel
      • 10.6.8.1. Israel: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.6.8.2. Israel: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.6.8.3. Israel: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.6.8.4. Israel: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.6.8.5. Israel: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.6.9. Cell Therapy Manufacturing Market - South Africa
      • 10.6.9.1. South Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.6.9.2. South Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.6.9.3. South Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.6.9.4. South Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.6.9.5. South Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.6.10. Cell Therapy Manufacturing Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.6.10.2. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.6.10.3. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.6.10.4. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.6.10.5. Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • 10.7. Cell Therapy Manufacturing Market - Latin America
    • 10.7.1. Latin America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
    • 10.7.2. Latin America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
    • 10.7.3. Latin America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
    • 10.7.4. Latin America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
    • 10.7.5. Latin America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.7.6. Cell Therapy Manufacturing Market - Mexico
      • 10.7.6.1. Mexico: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.7.6.2. Mexico: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.7.6.3. Mexico: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.7.6.4. Mexico: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.7.6.5. Mexico: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.7.7. Cell Therapy Manufacturing Market - Brazil
      • 10.7.7.1. Brazil: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.7.7.2. Brazil: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.7.7.3. Brazil: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.7.7.4. Brazil: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.7.7.5. Brazil: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.7.8. Cell Therapy Manufacturing Market - Argentina
      • 10.7.8.1. Argentina: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.7.8.2. Argentina: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.7.8.3. Argentina: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.7.8.4. Argentina: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.7.8.5. Argentina: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
    • 10.7.9. Cell Therapy Manufacturing Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
      • 10.7.9.2. Rest of Latin America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
      • 10.7.9.3. Rest of Latin America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
      • 10.7.9.4. Rest of Latin America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
      • 10.7.9.5. Rest of Latin America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. AGC Biologics
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Bayer AG
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Bio-Techne
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Catalent, Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Cell Therapies Pty Ltd.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Cellistic
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Charles River Laboratories
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Fujifilm Cellular Dynamics Inc.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Lonza Group AG
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Merck KGaA
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. Minaris Regenerative Medicine
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development
  • 12.12. Thermo Fisher Scientific Inc.
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Benchmarking
    • 12.12.4. Recent Development

List of Tables:

  • Table 1 Global Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 2 Global Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 3 Global Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 4 Global Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 5 Global Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 6 North America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 7 North America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 8 North America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 9 North America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 10 North America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 11 U.S.: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 12 U.S.: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 13 U.S.: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 14 U.S.: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 15 U.S.: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 16 Canada: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 17 Canada: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 18 Canada: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 19 Canada: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 20 Canada: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 21 Europe: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 22 Europe: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 23 Europe: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 24 Europe: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 25 Europe: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 26 UK: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 27 UK: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 28 UK: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 29 UK: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 30 UK: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 31 France: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 32 France: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 33 France: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 34 France: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 35 France: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 36 Germany: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 37 Germany: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 38 Germany: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 39 Germany: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 40 Germany: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 41 Italy: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 42 Italy: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 43 Italy: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 44 Italy: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 45 Italy: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 46 Spain: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 47 Spain: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 48 Spain: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 49 Spain: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 50 Spain: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 51 Netherlands: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 52 Netherlands: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 53 Netherlands: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 54 Netherlands: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 55 Netherlands: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 56 Russia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 57 Russia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 58 Russia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 59 Russia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 60 Russia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 61 Rest of Europe: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 62 Rest of Europe: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 63 Rest of Europe: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 64 Rest of Europe: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 65 Rest of Europe: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 66 Asia Pacific: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 67 Asia Pacific: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 68 Asia Pacific: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 69 Asia Pacific: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 70 Asia Pacific: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 71 China: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 72 China: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 73 China: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 74 China: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 75 China: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 76 India: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 77 India: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 78 India: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 79 India: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 80 India: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 81 Malaysia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 82 Malaysia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 83 Malaysia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 84 Malaysia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 85 Malaysia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 86 Japan: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 87 Japan: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 88 Japan: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 89 Japan: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 90 Japan: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 91 Indonesia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 92 Indonesia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 93 Indonesia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 94 Indonesia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 95 Indonesia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 96 South Korea: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 97 South Korea: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 98 South Korea: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 99 South Korea: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 100 South Korea: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 101 Australia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 102 Australia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 103 Australia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 104 Australia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 105 Australia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 106 Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 107 Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 108 Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 109 Rest of Asia Pacific: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 110 Rest of Asia Pacific: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 111 Middle East & Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 112 Middle East & Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 113 Middle East & Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 114 Middle East & Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 115 Middle East & Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 116 Saudi Arabia: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 117 Saudi Arabia: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 118 Saudi Arabia: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 119 Saudi Arabia: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 120 Saudi Arabia: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 121 UAE: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 122 UAE: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 123 UAE: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 124 UAE: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 125 UAE: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 126 Israel: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 127 Israel: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 128 Israel: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 129 Israel: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 130 Israel: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 131 South Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 132 South Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 133 South Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 134 South Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 135 South Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 136 Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 137 Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 138 Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 139 Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 140 Rest of Middle East & Africa: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 141 Latin America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 142 Latin America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 143 Latin America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 144 Latin America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 145 Latin America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 146 Mexico: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 147 Mexico: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 148 Mexico: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 149 Mexico: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 150 Mexico: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 151 Brazil: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 152 Brazil: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 153 Brazil: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 154 Brazil: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 155 Brazil: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 156 Argentina: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 157 Argentina: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 158 Argentina: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 159 Argentina: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 160 Argentina: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)
  • Table 161 Rest of Latin America: Cell Therapy Manufacturing Market, by Source, 2020-2034 (USD Billion)
  • Table 162 Rest of Latin America: Cell Therapy Manufacturing Market, by Cell Type, 2020-2034 (USD Billion)
  • Table 163 Rest of Latin America: Cell Therapy Manufacturing Market, by Indication, 2020-2034 (USD Billion)
  • Table 164 Rest of Latin America: Cell Therapy Manufacturing Market, by Scale of Operation, 2020-2034 (USD Billion)
  • Table 165 Rest of Latin America: Cell Therapy Manufacturing Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Cell Therapy Manufacturing Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Source
  • Figure 7. Global Cell Therapy Manufacturing Market, by Source, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Cell Type
  • Figure 9. Global Cell Therapy Manufacturing Market, by Cell Type, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Indication
  • Figure 11. Global Cell Therapy Manufacturing Market, by Indication, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Scale of Operation
  • Figure 13. Global Cell Therapy Manufacturing Market, by Scale of Operation, 2024 & 2034 (USD Billion)
  • Figure 14. Market by End User
  • Figure 15. Global Cell Therapy Manufacturing Market, by End User, 2024 & 2034 (USD Billion)